| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.12B | $1.05B | $992.5M |
| YoY Revenue Growth % | +6.7% | +6.0% | — |
| Gross Profit | $538.7M | $487.0M | — |
| Gross Margin % | 48.0% | 46.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $233.3M | $208.8M | $175.2M |
| Operating Margin % | 20.8% | 19.9% | 17.7% |
| Net Income (GAAP) | $151.6M | $118.7M | $80.7M |
| EBITDA (Normalized) | $256.2M | $226.7M | $211.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $256.0M | $212.1M | $184.5M |
| Capital Expenditures (CapEx) | $28.7M | $22.4M | $44.7M |
| Free Cash Flow (FCF) | $227.3M | $189.7M | $139.9M |
| FCF Margin % | 20.3% | 18.0% | 14.1% |
| Return on Invested Capital (ROIC %) | 9.4% | 8.5% | 12.8% |
| Cash & Short-Term Equivalents | $329.6M | $196.6M | — |
| Total Debt (Short + Long Term) | $701.1M | $705.1M | $417.6M |
| Total Stockholders' Equity | $1.59B | $1.42B | $856.6M |